Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) EPS (Basic): 2010-2025

Historic EPS (Basic) for Iovance Biotherapeutics (IOVA) over the last 9 years, with Sep 2025 value amounting to -$0.25.

  • Iovance Biotherapeutics' EPS (Basic) rose 10.71% to -$0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.19, marking a year-over-year increase of 20.13%. This contributed to the annual value of -$1.28 for FY2024, which is 32.28% up from last year.
  • As of Q3 2025, Iovance Biotherapeutics' EPS (Basic) stood at -$0.25, which was up 24.24% from -$0.33 recorded in Q2 2025.
  • Over the past 5 years, Iovance Biotherapeutics' EPS (Basic) peaked at -$0.25 during Q4 2024, and registered a low of -$0.50 during Q1 2023.
  • For the 3-year period, Iovance Biotherapeutics' EPS (Basic) averaged around -$0.37, with its median value being -$0.36 (2025).
  • Data for Iovance Biotherapeutics' EPS (Basic) shows a peak YoY soared of 44.44% (in 2024) over the last 5 years.
  • Iovance Biotherapeutics' EPS (Basic) (Quarterly) stood at -$0.45 in 2023, then spiked by 44.44% to -$0.25 in 2024, then climbed by 10.71% to -$0.25 in 2025.
  • Its EPS (Basic) stands at -$0.25 for Q3 2025, versus -$0.33 for Q2 2025 and -$0.36 for Q1 2025.